CD274 and head and neck squamous cell carcinoma: Furthermore, inhibition of the PD-1/PD-L1 axis in HNSCC can lead to compensatory upregulation of alternative immune checkpoints, such as TIM-3, LAG-3, CTLA-4, TIGIT, GITR, and VISTA [48,49].